Z-1524-2022 Class II Ongoing

Recalled by Luminex Corporation — Austin, TX

FDA device recall Z-1524-2022 was initiated by Luminex Corporation on July 14, 2022 and is designated Class II. Reason for recall: SARS-CoV-2 assay that detects SARS-CoV-2 ORF1ab and N genes may not detect the ORF1ab gene. A positive results if either SARS-CoV-2 genes is detected, but If both genes are mistakenly not detected, a … The recall status is ongoing. Affected quantity: 257.

Recall Details

Product Type
Devices
Report Date
August 24, 2022
Initiation Date
July 14, 2022
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
257

Product Description

ARIES SARS-CoV-2 Assay

Reason for Recall

SARS-CoV-2 assay that detects SARS-CoV-2 ORF1ab and N genes may not detect the ORF1ab gene. A positive results if either SARS-CoV-2 genes is detected, but If both genes are mistakenly not detected, a false negative result would be generated.

Distribution Pattern

U.S. Nationwide distribution in the states of NE, TX, MS, TN, KY, ME, CA.

Code Information

Lot: AB4042A